Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

46.72
Delayed Data
As of 4:02pm ET
 -0.41 / -0.87%
Today’s Change
45.80
Today|||52-Week Range
59.00
-19.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues4.0B4.2B4.0B4.1B
 
 
 
 
 
Cost of Goods Sold479.8M521.3M533.8M502.4M
 
 
 
 
 
Depreciation And Amortization94.5M147.3M92.3M108.2M
 
 
 
 
 
 
Operating ExpensesGross Income3.4B3.5B3.4B3.5B
 
 
 
 
 
General Expenses1.7B1.9B1.6B1.7B
 
 
 
 
 
Research And Development490.9M585.3M488.6M502.8M
 
 
 
 
 
Total Operating Expenses2.2B2.6B2.2B2.3B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.8B1.6B1.8B1.9B
 
 
 
 
 
Interest Expense On Debt4.6M4.6M6.8M14.9M
 
 
 
 
 
Other Expenses-236.7M-102.0M-7.2M40.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.5B1.5B1.8B1.9B
 
 
 
 
 
Income Taxes-261.7M-298.3M-369.4M-397.6M
 
 
 
 
 
Net Income1.3B1.2B1.4B1.5B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6B2.6B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.6B2.6B2.6B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.49$0.47$0.55$0.59
 
 
 
 
 
EPS Diluted$0.49$0.47$0.55$0.59